Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection-Reference-Cited by-同舟云学术

Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection

Published:2017-03-16 Issue:9 Volume:58 Page:1408-1413
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Goffin Karolien E.,Joniau Steven,Tenke Peter,Slawin Kevin,Klein Eric A.,Stambler Nancy,Strack Thomas,Babich John,Armor Thomas,Wong Vivien

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference36 articles.

1. The Expanding Role of MRI in Prostate Cancer

2. Initial prostate cancer diagnosis and disease staging—the role of choline-PET–CT

3. [177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer

4. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen;Smith-Jones;Cancer Res.,2000

5. Expression of Prostate-Specific Membrane Antigen in Normal and Malignant Human Tissues

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [99mTc]Tc-HYNIC-ALUG SPECT/CT in the initial staging of 227 consecutive patients with newly diagnosed prostate cancer: a 5-year monocentric retrospective study;Frontiers in Endocrinology;2024-02-20

2. DNA‐Targeted Complexes of Tc and Re for Biomedical Applications;Chemistry – A European Journal;2024-01-09

3. Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection;Theranostics;2024

4. Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT;Cancers;2023-12-13

5. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer;Molecular Imaging and Biology;2023-12-08